In osteosarcoma, overexpression of Hedgehog ligands and receptors, as well as mutations in pathway components, such as SMO and PTCH1, can result in increased Hedgehog signaling activity, promoting tumor growth and metastasis. This evidence concerns the gene PTCH1 and osteosarcoma.